首页> 外文期刊>Medicine. >A Case Report of Gastrointestinal Basidiobolomycosis Treated With Voriconazole A Rare Emerging Entity
【24h】

A Case Report of Gastrointestinal Basidiobolomycosis Treated With Voriconazole A Rare Emerging Entity

机译:伏立康唑A罕见新兴实体治疗胃肠道杆菌病的一例报道

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Basidiobolomycosis is an unusual fungal disease that rarely involves the visceral organs such as gastrointestinal tract. Gastrointestinal basidiobolomycosis (GIB) has been increasingly reported in the literature, and it is an emerging disease from arid regions worldwide, in particular, the south-western Saudi Arabia. We report a case of GIB in a 36-year-old Saudi Arabian male patient showing resistance to itraconazole and best treated with voriconazole. Computed tomography showed diffusely thickened small bowel with edematous change.Conclusions: As GIB presents diagnostic challenges due to lack of specific features, this case emphasizes the importance of considering GIB in the differential diagnosis in patients presenting with fever, abdominal pain with fast-growing abdominal mass.
机译:简介:芽孢杆菌病是一种罕见的真菌病,很少累及内脏器官,例如胃肠道。文献报道胃肠道芽孢杆菌病(GIB)越来越多,它是一种来自全球干旱地区,特别是西南沙特阿拉伯的新兴疾病。我们报告了一名36岁沙特阿拉伯男性患者的GIB病例,该患者显示出对伊曲康唑的抗药性,最好用伏立康唑治疗。计算机断层扫描显示小肠弥漫性增厚,弥漫性水肿。结论:由于缺乏特异性特征,GIB提出了诊断挑战,因此本例强调了在发烧,腹部疼痛,腹部快速增长的患者中进行GIB鉴别诊断的重要性质量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号